Accepted for/Published in: JMIR Bioinformatics and Biotechnology
Date Submitted: Jan 26, 2026
Open Peer Review Period: Jan 26, 2026 - Feb 3, 2026
Date Accepted: Sep 10, 2026
(closed for review but you can still tweet)
Sequence-Driven Classification of Aptamers by Target Type: Algorithm Development and Validation
ABSTRACT
Background:
DNA aptamers are short, single-stranded oligonucleotides that bind molecular targets with high affinity and specificity. Traditionally, aptamers are identified through SELEX (Systematic Evolution of Ligands by EXponential enrichment), an iterative process that is time-consuming and requires specialized equipment. To simplify and accelerate aptamer discovery, particularly across multiple mo-lecular targets, computational approaches have gained momentum.
Objective:
In this work, we present a sequence-only framework for classifying DNA ap-tamers by target type using curated datasets of experimentally validated sequences.
Methods:
Each sequence is represented using character-level TG-IDF of n-gram motifs. An ensemble of XGBoost classifiers is trained on these representations to distinguish between aptamers targeting cellular and steroidal molecules.
Results:
The model was further validated on a set of 13 newly selected aptamers for ster-oid aldosterone using experimental SELEX, achieving consistent predictive per-formance, confirming its ability to generalize new experimental data.
Conclusions:
These results demonstrate that informative target-specific patterns can be extract-ed directly from DNA sequences, establishing a scalable, data-driven comple-ment to SELEX for rapid pre-screening of candidate aptamers. Clinical Trial: None
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.